Justin Chakma, Chief Business Officer: ARS Pharmaceuticals SPRY Sell · Filed 24/12/13

Trade details

Type: Insider sale
Amount: $1,439,675.91
Shares · price: 117,333 sh · $12.27 a share
Held after: 136,380 sh
Stock: ARS Pharmaceuticals SPRY
Person: Justin ChakmaChief Business Officer
Trade date: 24/12/12
Filed: 24/12/13
Days to filing: 1 days

Sold 46.2% of holdings

Share of holding sold: 46.2%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/11/12~25/01/11

Justin Chakma's recent trades

Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$1.2M
136,380 sh
$1.2M
Filed 25/11/14
Traded 25/11/12
Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$267.3K
30,000 sh
$267.3K
Filed 25/11/14
Traded 25/11/12
Justin ChakmaChief Business Officer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$267.4K
30,000 sh
$267.4K
Filed 25/11/12
Traded 25/11/12
Justin ChakmaChief Business Officer
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$1.2M
138,380 sh
$1.2M
Filed 25/11/12
Traded 25/11/12
Justin ChakmaChief Business Officer
SellARS Pharmaceuticals
Sell
ARS Pharmaceuticals
SPRY
$328.9K
27,272 sh
$328.9K
Filed 24/12/13
Traded 24/12/13

Justin Chakma, Chief Officer — sold $1.4M of ARS Pharmaceuticals SPRY · 46.2% of holdings | Whalegun